The Glucose Grail: Raman Spectroscopy vs. Multispectral PPG in 2026

By Rizowan Ahmed (@riz1raj)
Senior Technology Analyst | Covering Enterprise IT, Hardware & Emerging Trends

The Glucose Grail: Why Your Watch Still Can't Track Sugar

The promise of non-invasive continuous glucose monitoring (NICGM) has been a long-standing industry challenge. As of 2026, the hardware has matured, but the physics of light-tissue interaction remains a significant barrier. If you are looking for a definitive solution, the technology is still in development.

Raman Spectroscopy: Precision and Challenges

Raman spectroscopy relies on the inelastic scattering of photons—the Raman effect. When a laser (typically in the near-infrared, 785nm or 830nm) interacts with interstitial fluid (ISF), the resulting frequency shift provides a molecular 'fingerprint' of glucose. It is chemically specific, but presents significant challenges for wearable integration.

• Signal-to-Noise Ratio (SNR): Raman signals are weak, requiring high-power lasers that must adhere to thermal safety constraints such as IEC 60825-1.
• Hardware Footprint: Despite miniaturized spectrometers using CMOS-based diffraction gratings, the optical path length required for a high-quality signal remains difficult to integrate into the thin chassis of a modern smartwatch.
• Motion Artifacts: Micro-movements can decouple the laser focus from the dermal layers, impacting the consistency of the data stream.

Multispectral PPG: The Statistical Approach

Conversely, multispectral PPG—the technology powering various attempts at Non-Invasive Continuous Glucose Monitoring (NICGM) via Multi-Wavelength Photoplethysmography (PPG) vs. Raman Spectroscopy—attempts to infer glucose concentrations by measuring changes in light absorption across multiple wavelengths. It relies on multivariate regression and machine learning.

The 2026 Technical Divide

The divergence between these two technologies involves different approaches to data acquisition. Raman is deterministic, identifying the molecule directly. Multispectral PPG is probabilistic, identifying a correlation between light attenuation and blood chemistry that can be influenced by hydration, skin temperature, and ambient light leakage.

Comparative Performance Matrix

• Accuracy (MARD): Raman systems in clinical research have demonstrated varying levels of Mean Absolute Relative Difference (MARD). PPG-based wearables face challenges in maintaining accuracy in uncontrolled, real-world environments.
• Latency: Raman requires integration times that make true 'continuous' monitoring a challenge. PPG offers lower latency but can suffer from drift over time.
• Power Budget: PPG sensors operate on low power budgets. Raman systems, even with MEMS-based spectrometers, require significant power for illumination and signal processing.

The Verdict: The State of Glucose Monitoring

The industry is currently focused on validation. Multispectral PPG is being deployed in consumer wearables as a 'wellness' feature, as it has not yet met the clinical requirements for insulin dosing. Raman spectroscopy, while technically precise, remains largely confined to benchtop or bulky prototypes.

Over the next 18 months, expect a focus on hybrid sensor fusion. The future may involve using PPG to track physiological trends and calibrating the model against localized Raman micro-sensors. Until the photonics industry achieves further breakthroughs in solid-state laser stability and CMOS sensitivity, consumer watches remain fitness trackers rather than medical monitors. The focus remains on the integration of multi-modal data sets.

---